跳至主要内容
临床试验/NCT04930211
NCT04930211Unknown不适用

The Effectiveness of Lumbar Transforaminal Anterior Epidural Steroid Injections in Discogenic Low Back Pain Associated With Modic Type-1 Change

Marmara University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年10月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
numeric rating scale

研究概览

简要总结

Modic changes have been associated with low back pain in many clinical studies and are often considered a part of the disc degeneration process. Modic type 1 change is considered an inflammatory process. The aim of this study is to determine the effectiveness of lumbar transforaminal epidural steroid injections in Modic type-1 changes.

详细描述

Modic changes have been associated with low back pain in many clinical studies and are often considered a part of the disc degeneration process. However, in degenerative disc disease, whether the pain could be attributed to Modic changes or not is still a matter of debate.

There are different options in the treatment of low back pain due to degenerative disc disease (DDD) and Modic changes. Conservative treatments and surgical approaches are some of them. Other interventional procedures include intradiscal and epidural steroid injections which have relatively less risk of complications than surgery.

The only study in the literature investigating the effectiveness of epidural steroid injections in patients with low back pain associated with modic changes belongs to Butterman et al. They reported that patients with Modic changes (type 1) responded better to epidural steroid injections than those without endplate irregularities. However, they did not report the details of the procedure, such as the steroid and local anesthetic they used, the amount of them and the level of the procedure. Moreover, they used different approaches including interlaminar and transforaminal, which may be misleading while interpreting the results.

Based on these results, the aim of this study is to determine the effectiveness of lumbar transforaminal epidural steroid injections in Modic type-1 changes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being between the ages of 18-65
  • Non-radicular, axial back pain
  • Lack of response to conservative treatments
  • Detection of Modic type 1 changes in contrast-enhanced Lumbar MRI or intervertebral disc findings that may be associated with discogenic pain (nuclear signal intensity change in the disc [black disc], height loss, or high-intensity zone)

排除标准

  • Patients younger than 18 and older than 65
  • Describing pain radiating to the lower extremity (those with radicular pain)
  • Nerve root compression due to disc herniation or other reasons
  • Modic changes in more than one level
  • Positive facet loading test
  • Spinal stenosis or spondylolisthesis
  • Diagnosed with spondylodiscitis
  • Pregnancy
  • Patients with inflammatory rheumatic diseases
  • Patients whose use of non-steroidal anti-inflammatory drugs is contraindicated (renal failure, bleeding disorders, etc.)
  • Patients with exercise intolerance

研究组 & 干预措施

Modic Type-1 changes

Active Comparator

Transforaminal Epidural Steroid Injection will be performed on patients at the pathology detected level bilaterally. The Kambin approach will be preferred in order to reach the intervertebral disc.

干预措施: Dexamethasone-Lidocaine (Drug)

Degenerative disc disease without Modic Type-1 changes

Active Comparator

Transforaminal Epidural Steroid Injection will be performed on patients at the pathology detected level bilaterally. The Kambin approach will be preferred in order to reach the intervertebral disc.

干预措施: Dexamethasone-Lidocaine (Drug)

结局指标

主要结局

numeric rating scale

时间窗: sixth month

a scale used to measure the severity of pain. "0" is scored as no pain, "10" as the most

次要结局

  • Oswestry disability index(sixth month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验